Management of people with haemophilia A undergoing surgery while receiving emicizumab prophylaxis: Real-world experience from a large comprehensive treatment centre in the US.

Magdalena LewandowskaNicole RandallNihal BakeerJennifer MaahsJeanne SagarAnne GreistAmy D Shapiro

Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2020)

Additional haemostatic agent use is safe in PwHA undergoing surgery while receiving emicizumab. Additional data are needed to determine the optimal dosing/length of treatment of additional haemostatic agents to lower bleeding risk.

Keyphrases

minimally invasive
coronary artery bypass
atrial fibrillation
coronary artery disease
machine learning
combination therapy
surgical site infection
replacement therapy
artificial intelligence
data analysis